The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Hidradenitis Suppurativa: Advances in Diagnosis and Treatment
Abstract
IMPORTANCE: Hidradenitis suppurativa (HS) is relatively common, with the prevalence of 0.05% to 4.10%, yet many patients receive inadequate treatment. OBJECTIVE: To review the diagnosis, epidemiology, and treatment of HS with an emphasis on advances in the last 5 years. EVIDENCE REVIEW: A literature search was conducted using PubMed, MEDLINE (Medical Subject Headings [MeSH]), and EMBASE to include recently published treatment studies (searched from September 1, 2011, to May 1, 2017). Reviews, guidelines, conference abstracts, and studies with less than 10 patients were excluded. Furthermore, internet searches for guidelines on hidradenitis suppurativa using Baidu, Bing, Google, and Qwant browsers were performed. FINDINGS: The diagnosis of HS is made by lesion morphology (nodules, abscesses, tunnels, and scars), location (axillae, inframammary folds, groin, perigenital, or perineal), and lesion progression (2 recurrences within 6 months or chronic or persistent lesions for ≥3 months). HS is more common than was previously thought based on epidemiological analysis (0.05%-4.10%). Disability from HS can be significant. Patients with HS may have significant comorbidities (eg, obesity, metabolic syndrome, diabetes, and arthritis) and increased all-cause mortality (incidence rate ratio, 1.35 [95% CI, 1.15-1.59]). Antibiotic treatment with combinations of clindamycin and rifampicin, or ertapenem followed by combination rifampicin, moxifloxacin, and metronidazole for 6 months is effective. Adalimumab is effective in a significant proportion of patients and treatment with IL-1 and IL-12 receptor subunit beta 1 (Rb1) antibodies may also be useful. Tissue-sparing surgical techniques and carbon dioxide laser treatments also are available, but the evidence on clinical outcomes with these approaches is limited. CONCLUSIONS AND RELEVANCE: Hidradenitis suppurativa is more common than previously thought and may be treated by an array of pharmacological and surgical techniques. Hidradenitis suppurativa should be considered in the differential diagnosis of nodular lesions or sinus tracts present in the axillae, groin, perineal, and mammillary fold regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., Armstrong, A. W., Kerdel, F., Gold, M. H., Forman, S. B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504370 · Cited by 807
Self-citationObjective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Sartorius, K., Emtestam, L., Jemec, G. B. E., & Lapins, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09198.x · Cited by 525
Self-citationvan der Zee, H. H., de Ruiter, L., van den Broecke, D. G., Dik, W. A., Laman, J. D., & Prens, E. P. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10254.x · Cited by 472
Kimball, A. B., Kerdel, F., Adams, D., Mrowietz, U., Gelfand, J. M., Gniadecki, R., Prens, E. P., Schlessinger, J., Zouboulis, C. C., van der Zee, H. H., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-12-201212180-00004 · Cited by 428
Self-citationDiagnostic delay in hidradenitis suppurativa is a global problem
Saunte, D. M., Boer, J., Stratigos, A., Szepietowski, J. C., Hamzavi, I., Kim, K. H., Zarchi, K., Antoniou, C., Matusiak, L., Lim, H. W., et al. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14038 · Cited by 398
Self-citationZouboulis, C. C., del Marmol, V., Mrowietz, U., Prens, E. P., Tzellos, T., & Jemec, G. B. E. (2015) · Dermatology · doi:10.1159/000431175 · Cited by 376
Self-citationBenson, J. M., Peritt, D., Scallon, B. J., Heavner, G. A., Shealy, D. J., Giles-Komar, J. M., & Mascelli, M. A. (2011) · mAbs · doi:10.4161/mabs.3.6.17815 · Cited by 340
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa
Jemec, G. B. E., & Wendelboe, P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70272-5 · Cited by 338
Self-citationDysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
Kelly, G., Hughes, R., McGarry, T., Born, M., Adamzik, K., Fitzgerald, R., Lawlor, C., Tobin, A. M., Sweeney, C. M., & Kirby, B. (2015) · British Journal of Dermatology · doi:10.1111/bjd.14075 · Cited by 306
Depression in patients with hidradenitis suppurativa
Onderdijk, A. J., van der Zee, H. H., Esmann, S., Lophaven, S., Dufour, D. N., Jemec, G. B. E., & Boer, J. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04468.x · Cited by 271
Self-citation
Cited by
Sabat, R., Jemec, G. B. E., Matusiak, Ł., Kimball, A. B., Prens, E., & Wolk, K. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0149-1 · Cited by 573
Self-citationEmerging Topical and Systemic JAK Inhibitors in Dermatology
Solimani, F., Meier, K., & Ghoreschi, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02847 · Cited by 308
Hidradenitis Suppurativa: Where We Are and Where We Are Going
Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G. (2021) · Cells · doi:10.3390/cells10082094 · Cited by 135
Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
Vecin, N., Balukoff, N. C., Yaghi, M., Gonzalez, T., Sawaya, A. P., Strbo, N., Tomic-Canic, M., Lev-Tov, H., & Pastar, I. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100350 · Cited by 10
Metadata
- Authors
- Saunte, D. M. L., & Jemec, G. B. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-11-28
- Volume
- 318
- Issue
- 20
- Pages
- 2019
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2768740770
- Cited by
- 492
- References
- 50
- FWCI
- 38.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. https://app.cochat.ai/papers/10.1001/jama.2017.16691
- The paper
- Saunte, D. M. L., & Jemec, G. B. E. (2017). Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA. https://doi.org/10.1001/jama.2017.16691
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.